3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
3
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
39
Nivolumab
13
Cisplatin
12
Paclitaxel
11
Docetaxel
11
Carboplatin
10
atezolizumab
9
Trastuzumab
9
Gemcitabine
9
Cyclophosphamide
8
fludarabine
7
Bevacizumab
7
aldesleukin
6
durvalumab
5
Taxes
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Leucovorin
5
Irinotecan
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
avelumab
4
Specimen Handling
4
Psychiatric Rehabilitation
4
Ipilimumab
4
Drug Therapy
4
Cetuximab
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
tislelizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Radionuclide Imaging
×
Thoracic
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled